ctrl K

Watchlist Price Alert

Estrella Immunopharma Inc... (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

0.91

-0.03 (-3.19%)

At close: Jun 27, 2025, 11:21 AM

Estrella Immunopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	4.17M	40.8K	4.09M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	9.67M	45.19M	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	288.76K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	4.45M	52.43K	4.92M	n/a
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	9.93M	45.19M	n/a
Total Assets	4.45M	9.99M	4.92M	n/a
Account Payables	n/a	46.88K	945.59K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	498.6K	n/a	n/a
Other Current Liabilities	129.72K	8.79M	n/a	n/a
Total Current Liabilities	180.7K	1.07M	946.68K	n/a
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.55M	5.01M	n/a
Total Long-Term Liabilities	n/a	1.84M	5.01M	n/a
Total Liabilities	180.7K	2.92M	5.96M	n/a
Total Debt	n/a	498.6K	n/a	n/a
Common Stock	3.66K	9.33M	18.00	n/a
Retained Earnings	-19.5M	-2.26M	-1.07M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	4.27M	7.07M	-1.04M	n/a
Total Investments	n/a	9.67M	45.19M	n/a